Considering a broad scope of 4D printing in healthcare industry, several industrial players are shifting to technological innovation for manufacturing surgical robots that can perform variety of surgical tasks with higher precision, biomedical splints, implants and smart biomaterials. In July 2025, Frisco Public Library entered into partnership with Xinyl Xiao in order to launch its first public class on 4D printing program. Unlike conventional 3D printing, 4D printing helps to create structures...

The CRISPR based genome editing service market, valued at USD 2.1 billion in 2025, is projected to reach USD 2.7 billion in 2026 and USD 5.9 billion by 2030, with a 22.1% CAGR during the forecast period 2026 to 2030. The 1970s witnessed the introduction of one of the most revolutionary advances in biotechnology, when Hamilton Smith purified the 1st site-specific restriction enzyme, called Hind II. Soon after, in the 1980s, the US FDA approved the world

The global market for cryopreservation bags and freezing bags, valued at USD 216 million in 2025, is projected to reach USD 224 million in 2026 and USD 316 million by 2035, with a 3.9% CAGR during the forecast period 2026 to 2035. The cryopreservation bags and freezing bags providers landscape features a mix of large, mid-sized and small companies that offer various cryobags. Presently, more than 70 cryogenic storage bags for biologic products have been / are being developed by over 30 industry...

The global wireless healthcare market, valued at USD 223.83 billion in 2024, is projected to reach USD 275.91 billion in 2025 and USD 1,452.75 billion by 2035, representing a CAGR of 18.1% during the forecast period. One of the key objectives of wireless healthcare market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. wireless healthcare market report, presently wireless personal area network accounts for the highest sh...

The global drug bioavailability enhancement market, valued at USD 3.6 billion in 2025, is projected to reach USD 4.0 billion in 2026 and USD 10.2 billion by 2035, with a 11.1% CAGR during the forecast period 2026 to 2035. A search study found that most candidates fail during the early phases of clinical trials. The study also underscored that almost 90% of New Chemical Entities (NCEs) in pre-clinical and clinical stages face solubility or permeability challenges. Consequently, there has been a n...

The diet and nutrition apps market is estimated to grow from USD 5.06 billion in 2024 to reach USD 6.13 billion in 2025 and USD 28.36 billion by 2035, representing a high CAGR of 16.6% during the forecast period. One of the key objectives of the diet and nutrition apps market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. According to our diet and nutrition apps market report, presently, weight loss / gain tracking apps...

The generative AI in healthcare market, valued at USD 3.3 billion in 2025, is projected to reach USD 4.7 billion in 2026 and USD 39.8 billion by 2035, with a 26.7% CAGR during the forecast period 2026 to 2035. Implementing generative AI in pharma for administrative tasks can lead to substantial annual savings (of around $150 billion) across the healthcare sector. Furthermore, a study shows that it can reduce diagnostic errors by around 85% and reduce nursing overtime by 21%, translating into the...

Currently, the global market for glycobiology is valued at USD 1.95 billion in 2025 and is poised to reach USD 6.77 billion by 2035, representing a CAGR of 13.2% during the forecast period. This lucrative growth is likely to be the result of increasing research on glycomics.To leverage the competitive edge, several industrial players are driving innovations, investments and partnerships in this field. For instance, in December 2024, GlycoNet (global leader in glycomics research and innovations)...

Several industrial players are currently focusing on the development of advanced PCSK9 inhibitors and exploring more therapeutic potential. For instance, in June 2025, Merck (US) announced positive results of enlicitide decanoate, an investigation oral PCSK9 from the first two of three phase III clinical trials evaluating safety and efficacy. This drug is being evaluated under clinical trial for the treatment of adults with hyperlipidemia on lipid-lowering therapies. These positive outcomes and...

The patient engagement solutions market, valued at USD 18.0 billion in 2025, is projected to reach USD 21.6 billion in 2026 and USD 96.7 billion by 2035, with a 18.1% CAGR during the forecast period 2026 to 2035. The current patient engagement solution providers landscape features around 420 large, mid-sized and small companies. It is worth mentioning that 98% of the solution providers offer solutions for home health management and more than 75% of the solution providers offer cloud-based deploy...

The global long acting drugs market, valued at USD 1.29 billion in 2025, is projected to reach USD 1.55 billion in 2026 and USD 4.62 billion by 2035, with a 12.9% CAGR during the forecast period 2026 to 2035. Many stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players for technology licensing, product development and manufacturing purposes. It is worth highlighting that over 90 strategic partnerships have been inked since 2018 in this mark...

With growing concern of genetic disorders and chronic conditions across the globe, the healthcare industry has necessitated the carrier screening of prenatal and newborn. Several government organizations and industrial players are focusing on strategic initiatives to enhance carrier screening of individuals to determine couples at greater risk of genetic conditions. For instance, KK Women’s and Children’s Hospital and Temasek Foundation conjointly launched Temasek Foundation PREDICT (Parenth...

The global lyophilization services market, valued at USD 3.0 billion in 2025, is projected to reach USD 3.2 billion in 2026 and USD 4.7 billion by 2035, with a 4.3% CAGR during the forecast period 2026 to 2035. Antibodies market segment holds the largest share of the market and are poised to capture 52% of the overall revenue share by 2035.

Recent research published by researchers at Mount Sinai in January 2025, led by Josep M. Llovet, MD, PhD, Professor of Medicine (Liver Diseases) at the Icahn School of Medicine at Mount Sinai have made a breakthrough in the treatment of hepatocellular carcinoma with combination approach. Under Phase III clinical study, “LEAP-012: Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma,” has show...

The global pen injectors market size, valued at USD 43.85 billion in 2024, is projected to reach USD 47.22 billion in 2025 and USD 87.19 billion by 2035, representing a CAGR of 6.3% during the forecast period. North America holds the largest share (41%), notably, Asia-Pacific is expected to see the highest growth due to increasing chronic illness rates and expanding healthcare access.

The biopreservation market for media, valued at USD 1.9 billion in 2025, is projected to reach USD 2.3 billion in 2026 and USD 15.5 billion by 2035, with a 23.6% CAGR during the forecast period 2026 to 2035. At present, over 60 players claim to offer more than 190 biopreservation and biobanking, intended for storage and preservation of different types of biological samples. Further, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it w...

The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period. The new research study consists of industry trends, detailed market analysis, clinical trial analysis, likely drug candidates and market impact analysis, along with the market forecast and opportunity analysis. Currently, there are more than 1,000 cell and gene therapies under development, most of which are being d...

The global biohacking market, valued at USD 23.63 billion in 2024, is projected to reach USD 28.73 billion in 2025 and USD 137.37 billion by 2035, representing a CAGR of 16.9% during the forecast period. As more market players continue to accelerate innovation in this field, we believe the global biohacking industry will continue to expand at a steady rate during the forecast period.

The global women health app market, valued at USD 3.45 billion in 2024, is projected to reach USD 5.29 billion in 2025 and USD 27.00 billion by 2035, representing a CAGR of 17.7% during the forecast period. Presently menstrual health holds the highest share (34%) of the market. Smartphone segment holds 59% of the overall revenue share. North America contributed 39% of the revenue share. Based on the type of age group, the global market for women health app is distributed into 15 to 24 years, 25...

The global biosimulation market size, valued at USD 3.45 billion in 2024, is projected to reach USD 4.18 billion in 2025 and USD 19.69 billion by 2035, representing a CAGR of 16.8% during the forecast period. According to our market report, presently the software segment occupies the highest biosimulation market share (62%), and the trend is likely to remain unchanged during the forecast period.